Pediatrix Medical (MD) Common Equity (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Common Equity data on file, last reported at $878.6 million in Q1 2026.

• Common Equity for Q1 2026 came in at $878.6 million, up 11.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $878.6 million (up 11.33% YoY), and the FY2025 annual result was $865.9 million, up 13.19% from the prior year.
• Common Equity rose to $878.6 million in Q1 2026 per MD's latest filing, from $865.9 million in the prior quarter.
• Over five years, Common Equity peaked at $968.0 million in Q3 2023 and troughed at $706.5 million in Q2 2024.
• A 5-year average of $850.6 million and a median of $858.7 million in 2022 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2025: Common Equity slipped 25.03% in 2024, then climbed 21.59% in 2025.
• A 5-year view of Common Equity shows it stood at $891.6 million in 2022, then slipped by 4.77% to $849.1 million in 2023, then slipped by 9.91% to $764.9 million in 2024, then climbed by 13.19% to $865.9 million in 2025, then climbed by 1.47% to $878.6 million in 2026.
• Business Quant data shows MD's Common Equity at $878.6 million in Q1 2026, $865.9 million in Q4 2025, and $890.7 million in Q3 2025.